Literature DB >> 2542288

Two different subunits associate to create isoform-specific platelet-derived growth factor receptors.

R A Seifert1, C E Hart, P E Phillips, J W Forstrom, R Ross, M J Murray, D F Bowen-Pope.   

Abstract

Recent evidence has demonstrated that there is more than one form of platelet-derived growth factor (PDGF) receptor and that these receptors differ in their specificity for the multiple isoforms of PDGF. We present evidence that high affinity binding of PDGF requires association of two different receptor subunits: an alpha-subunit that can bind either a B- or an A-chain of PDGF, and a beta-subunit that can bind only a B-chain. The alpha- and beta-subunits appear to be similar in size but can be distinguished by binding specificity and by an antireceptor monoclonal antibody, PR7212, which recognizes only the beta-subunit. In the absence of PDGF, these subunits either exist separately or form rapidly reversible complexes. In the presence of PDGF, receptor subunits of appropriate specificity interact with a PDGF molecule to form a high affinity complex. Both the absolute and relative numbers of these two PDGF receptor subunits vary on different cell types and correspond to differences in the mitogenic sensitivity of cells to the different PDGF isoforms.

Mesh:

Substances:

Year:  1989        PMID: 2542288

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  132 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Chimera analysis reveals that fibroblasts and endothelial cells require platelet-derived growth factor receptorbeta expression for participation in reactive connective tissue formation in adults but not during development.

Authors:  J R Crosby; K A Tappan; R A Seifert; D F Bowen-Pope
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 3.  DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors.

Authors:  P D'Orléans-Juste; M G Sirois; E R Edelman; D Regoli; L H Pheng; G Bkaily; C J Lindsey
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 4.  Molecular aspects of pathological processes in the artery wall.

Authors:  J W van Neck; H P Bloemers
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

5.  Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.

Authors:  Koichi Kozaki; Wolfgang E Kaminski; Jingjing Tang; Stan Hollenbach; Per Lindahl; Carol Sullivan; Jin-Chen Yu; Keith Abe; Paul J Martin; Russell Ross; Christer Betsholtz; Neill A Giese; Elaine W Raines
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

6.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.

Authors:  L Petti; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta.

Authors:  L D Cunningham; P Brecher; R A Cohen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.

Authors:  M Ebbecke; C Unterberg; A Buchwald; S Stöhr; V Wiegand
Journal:  Basic Res Cardiol       Date:  1992 Nov-Dec       Impact factor: 17.165

9.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

Review 10.  Kidney epithelial cells release growth factors in response to extracellular signals.

Authors:  F G Toback; M M Walsh-Reitz; S R Mendley; S Kartha
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.